APOD: reasoning-guided agentic population ordinary differential equation discovery for pharmacological digital twins
On the map: LLM agents and tool use → Medical and scientific domain agents
Abstract (arXiv)
Establishing ordinary differential equations (ODEs) describing population data is a fundamental part of mathematical modeling in pharmacology, crucial to developing digital twins. However, doing so from sparse, noisy data is a slow, expert-driven task. Existing automated methods either search a restricted model space or ignore population inter-individual variability. Here we introduce APOD (Agentic Population ODE Discovery), a language-model agent that iteratively reasons over biological knowledge and fit diagnostics in an open-ended search space to discover a population digital twin (PDT), i.e., a shared ODE system with between-subject variability. On synthetic pharmacokinetic and tumor-dynamics benchmarks, APOD recovered ground-truth structures in 94-100% of runs, 12-fold faster in median than an established library-based search. On real cohorts it converged to valid structures, and proposed a PDT of radioligand-therapy-induced platelet dynamics that predicts thrombocytopenia from first-cycle data and simulates alternative dosing schedules that lower the predicted risk of toxicity.
Key facts. No citing papers in the map yet (data through 7 Oct 2026). Placed in Medical and scientific domain agents, one of 16 directions in LLM agents and tool use. First posted on arXiv 5 Oct 2026.
Builds on
No reference list yet.
Built on by
Not cited yet.
Similar, not cited
Close in wording, no citation either way
- 2026Automatic Ordinary Differential Equations Discovery For Biological Systems Using Large Language Model Powered Agentic System
- 2025MADD: Multi-Agent Drug Discovery Orchestra
- 2025LLM Agent Swarm for Hypothesis-Driven Drug Discovery
- 2026TxBench-PP: Analyzing AI Agent Performance on Small-Molecule Preclinical Pharmacology
- 2024DrugAgent: Reliable Multi-Agent Integration of Conflicting Biomedical Evidence for Drug-Target Interaction Assessment
- 2025AI Agents in Drug Discovery
- 2025MedAI: Evaluating TxAgent's Therapeutic Agentic Reasoning in the NeurIPS CURE-Bench Competition
- 2025TxAgent: An AI Agent for Therapeutic Reasoning Across a Universe of Tools